Physician profile
Nathan Michael Wick
NPI 1992366504
$8,190.29
in general payments reported to CMS, 2019-2025
16 companies · $2,979 in 2025
The $2,979 reported for 2025 was more than what 97% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $36.53 · 2021: $103 · 2023: $2,609 · 2024: $2,463 · 2025: $2,979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,850 · Education: $1,135 · Travel and Lodging: $1,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,850.13 |
| Education | $1,134.80 |
| Travel and Lodging | $1,065.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,240.20 | 2023-2024 | Senza |
| Boston Scientific Corporation | $1,622.42 | 2024-2025 | Intracept |
| Medtronic, INC. | $806.24 | 2023-2025 | Intellis Adaptivestim, Vectris Surescan, Inceptiv |
| Saluda Medical Americas, INC. | $504.41 | 2024-2025 | Evoke |
| Globus Medical, INC. | $416.09 | 2025 | Senza, Corridor |
| Biotronik Nro, INC. | $333.51 | 2025 | Prospera |
| Avanos Medical | $285.73 | 2020-2024 | Coolief* Cooled Radiofrequency, On-Q* Pump and Accessories |
| Spr Therapeutics, INC | $221.14 | 2024-2025 | Sprint Pns System |
| Nalu Medical, INC. | $189.54 | 2023-2024 | Nalu Neurostimulation System |
| Mml US, INC. | $163.98 | 2025 | Reactiv8 |
| Merz Pharmaceuticals, LLC | $125.00 | 2023 | Xeomin |
| Abbvie INC. | $102.91 | 2021 | |
| Abbott Laboratories | $78.30 | 2024-2025 | Proclaim |
| Vertos Medical, INC. | $66.83 | 2023 | Mild Device Kit |
| Curonix LLC | $17.46 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Wick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.